Implications of Single-Vessel Runoff on Long Term Outcomes of Free Tissue Transfer for Lower Extremity Reconstruction.
Citation: Journal of Reconstructive Microsurgery. 2023 Sep 26PMID: 37751882Institution: MedStar Heart & Vascular Institute | MedStar Washington Hospital CenterDepartment: MedStar Georgetown University Hospital/MedStar Washington Hospital Center | Plastic Surgery Residency | Surgery/Plastic SurgeryForm of publication: Journal ArticleMedline article type(s): Journal ArticleSubject headings: IN PROCESS -- NOT YET INDEXED | Year: 2023ISSN:- 0743-684X
- Bekeny, Jenna C:
- https://orcid.org/0000-0002-7517-4326
Item type | Current library | Collection | Call number | Status | Date due | Barcode |
---|---|---|---|---|---|---|
Journal Article | MedStar Authors Catalog | Article | 37751882 | Available | 37751882 |
BACKGROUND: Patients with complex lower extremity (LE) wounds and single-vessel LE runoff (1-VRO) are often considered for amputation. While more challenging, free tissue transfer (FTT) is a means for limb salvage. This study aims to demonstrate the feasibility of limb salvage with FTT in patients with 1-VRO.
CONCLUSION: This study demonstrates that FTT reconstruction to the LE remains a reliable reconstruction option for limb-salvage in patients with single-vessel supply to the LE. Reliance on advanced perioperative management and patient optimization is effective at reducing negative outcomes. Copyright Thieme. All rights reserved.
METHODS: Patients undergoing FTT by a single surgeon between 2011 and 2021 were retrospectively reviewed. Data collected included demographics, wound characteristics, vascular status, and operative details. Patients were divided into cohorts based on 1- vs. 3-VRO of tibial vessel inflow. Outcomes of interest included postoperative complications such as flap necrosis, flap success, limb salvage, and ambulatory status.
RESULTS: A total of 188 patients underwent FTT to LE, with 25 patients (13.3%) having 1-VRO. Patients with 1-VRO had a comparable prevalence of diabetes (56.0% vs. 50.0%, p=0.569) and end-stage renal disease (8.0% vs. 3.7%, p=0.319). Osteomyelitis was more common in the 1-VRO group (80.0% vs. 60.1%, p=0.056). FTT donor sites and flap composition were similar between cohorts. At mean follow-up of 21.2 months (IQR 24.5: 5.6, 30.1 months), limb salvage rates were similar between cohorts (84.0% vs. 91.4%, p=0.241), with no significant differences in ambulatory status or mortality. Higher complication rates occurred in the 1-VRO cohort (48.0% vs. 21.5%, p=0.004), of which partial flap necrosis was more prevalent in the 1-VRO group (8.0% vs. 1.2%, p=0.029). There was no difference in flap success rates between groups (p=0.805). More post-flap angiograms were performed in the 1-VRO group (32.0% vs. 9.2%, p=0.001), but there was no difference in need for repeat percutaneous endovascular intervention between groups.
English